John V. W. Reynders
Directeur/Bestuurslid bij Rare-X
Oorsprong van het eerstegraads netwerk van John V. W. Reynders
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 94 | |
Rare-X
 Rare-X Packaged SoftwareTechnology Services Part of Global Genes, Rare-X is a patient advocacy organization based in Washington. Rare-X is focused on supporting the acceleration and development of life-altering treatments and future cures for patients impacted by a rare disease. Rare-X is building the largest collaborative patient-driven, open-data access project for rare diseases ly, gathering structured, fit-for-purpose data to share broadly, benefitting from 21st-century governance, consent, and federated data sharing technology. Rare-X's goal is to build the largest collaborative patient-driven, open-data access project for rare diseases ly. The American company was founded in 2019 by Nicole Boice. The CEO is Charlene Son Rigby. Rare-X was acquired by Global Genes on February 07, 2023.
17
| Subsidiary | Packaged Software | 17 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met John V. W. Reynders via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Investor Relations Contact Chief Tech/Sci/R&D Officer Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal Compliance Officer | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
| ABEONA THERAPEUTICS INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| BIOGEN INC. | Pharmaceuticals: Major | Sales & Marketing Director of Finance/CFO Investor Relations Contact Corporate Officer/Principal | |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director of Finance/CFO Public Communications Contact | |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Biotechnology | Human Resources Officer Sales & Marketing | |
| ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | President Director/Board Member | |
| ACCELERON PHARMA INC. | Biotechnology | Chairman Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Corporate Secretary Director/Board Member Director/Board Member Corporate Officer/Principal | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| BAXALTA INC | Biotechnology | Director/Board Member Human Resources Officer Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Public Communications Contact Corporate Officer/Principal | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Doctorate Degree Graduate Degree | |
| BLUEBIRD BIO, INC. | Biotechnology | Public Communications Contact Chief Tech/Sci/R&D Officer Comptroller/Controller/Auditor | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Compliance Officer | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Undergraduate Degree | |
| Colby College | College/University | Corporate Officer/Principal Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | College/University | Doctorate Degree Doctorate Degree | |
Biotechnology Research & Development Corp.
 Biotechnology Research & Development Corp. Miscellaneous Commercial ServicesCommercial Services Biotechnology Research & Development Corp. provides research on animal and plant healthcare, material sciences and biotechnology. The company is headquartered in Peoria, IL. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| UNIQURE N.V. | Biotechnology | Director/Board Member Director/Board Member | |
| SYROS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin | |
| Yale School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Comptroller/Controller/Auditor | |
Gemini Therapeutics Sub, Inc.
 Gemini Therapeutics Sub, Inc. BiotechnologyHealth Technology Gemini Therapeutics Sub, Inc. engages in the development of treatments for age-related macular degeneration (AMD) and linked ocular disorders. Its multimodal pipeline includes monoclonal antibodies, recombinant proteins and gene therapies. The company was founded by James McLaughlin, Johanna Seddon, Paul Barlow and Andrew Herbert in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Chairman Chief Executive Officer | |
BenevolentAI Ltd.
 BenevolentAI Ltd. Packaged SoftwareTechnology Services Part of BenevolentAI SA, BenevolentAI Ltd. develops artificial intelligence applications. The company is based in London, UK. The British company was founded in 2015 by Kenneth Patrick Mulvany, Ivan Griffin, Michael Brennan. BenevolentAI was acquired by Odyssey Acquisition SA on April 22, 2022 for $1,087.33 million. | Packaged Software | Chairman Director/Board Member | |
| ALLOVIR, INC. | Biotechnology | President Chairman General Counsel Director/Board Member Chief Tech/Sci/R&D Officer | |
| KRYSTAL BIOTECH, INC. | Biotechnology | Director/Board Member Director/Board Member | |
SpringWorks Therapeutics LLC
 SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | Biotechnology | Director/Board Member Chief Executive Officer | |
| KYMERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member General Counsel Director/Board Member | |
| SCHOLAR ROCK HOLDING CORPORATION | Biotechnology | Chairman Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| MODERNA, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| DYNE THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| SPRINGWORKS THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Executive Officer General Counsel Chief Tech/Sci/R&D Officer | |
ElevateBio LLC
 ElevateBio LLC BiotechnologyHealth Technology ElevateBio LLC is a biotechnology holding company, which creates and operates a broad portfolio of cell and gene therapy companies. It builds single and multi-product companies by providing scientific founders with bench-to-bedside capabilities including scientists, manufacturing facilities, drug developers, and commercial expertise. The company was founded by David L. Hallal, Vikas Sinha, and Mitchell H. Finer and is headquartered in Cambridge, MA. | Biotechnology | Founder Chief Executive Officer | |
| COMPASS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Sionna Therapeutics, Inc.
 Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | Medical/Nursing Services | Director of Finance/CFO Chairman | |
| RALLYBIO CORPORATION | Biotechnology | Founder General Counsel | |
LifeEDIT Therapeutics, Inc.
 LifeEDIT Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of ElevateBio LLC, LifeEDIT Therapeutics, Inc. is a next-generation genome editing company that has built a highly innovative platform with one of the world's largest and most diverse collections of novel RNA-guided nucleases (RGNs) and base editors. The company offers gene editing tools with higher fidelity, novel functionality, reduced immune response risk, and easier delivery. LifeEDIT has a large and diverse library of RGNs, including type II and type V systems that encompass knock-out and knock-in capabilities, transcriptional regulation, and base editing when coupled with one of their proprietary deaminases. The company's nuclease collection has a broad range of protospacer adjacent motifs (PAMs), offering unprecedented access to genomes. LifeEDIT is headquartered in Morrisville, NC. The CEO of the company is Mitchell H. Finer. LifeEDIT Therapeutics was acquired by ElevateBio LLC from AgBiome Delta LLC on October 27, 2021. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| BENEVOLENTAI | Biotechnology | Chief Executive Officer Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 46 |
| Verenigd Koninkrijk | 3 |
| Nederland | 2 |
| Luxemburg | 2 |
Sectoraal
| Health Technology | 35 |
| Consumer Services | 9 |
| Commercial Services | 5 |
| Health Services | 3 |
| Finance | 2 |
Operationeel
| Director/Board Member | 326 |
| Corporate Officer/Principal | 232 |
| Independent Dir/Board Member | 122 |
| Undergraduate Degree | 74 |
| Chief Executive Officer | 55 |
Sterkste connecties
| Insiders | |
|---|---|
| Stephen P. Squinto | 40 |
| Felix Baker | 28 |
| Francois Nader | 28 |
| Martin MacKay | 28 |
| Rockford Norby | 28 |
| William Keller | 26 |
| M. Burns | 23 |
| Dave Anderson | 21 |
| Paul Friedman | 21 |
| Deborah Dunsire | 19 |
| Camille Bedrosian | 18 |
| Judith Reinsdorf | 18 |
| Bill Lundberg | 17 |
| Ellen Chiniara | 16 |
| Julie O'Neill | 16 |
- Beurs
- Insiders
- John V. W. Reynders
- Bedrijfsconnecties